#London #United Kingdom #Tender Offer #bonds #Haleon plc

Haleon plc Cash Tender Offer: 3.375% Senior Notes

On August 11, 2026, Haleon plc, a prominent player in consumer healthcare, announced an initiative aimed at optimizing its debt portfolio through a cash tender offer for its outstanding 3.375% Fixed Rate Senior Notes due March 2027. The total amount for these notes stands at approximately $1.999 billion. This move is part of the company’s broader strategy to effectively manage its capital allocation and enhance its financial health.

Details of the Tender Offer

The tender offer is led by Haleon’s fully owned subsidiary, Haleon US Capital LLC. Bondholders holding the targeted notes will be offered a price reflecting the Total Consideration, which is calculated based on the Reference Yield and the Fixed Spread, besides accrued interest. This strategic buyback is expected to reinforce Haleon's commitment to financial prudence and maintain agility in its capital structure.

Key Features of the Tender Offer:

• - Amount: Approximately $1,999,350,000 of 3.375% Fixed Rate Senior Notes.
• - Expiration Date: The offer will remain open until 5:00 PM, New York City time, on August 18, 2026.
• - Tender Conditions: The offer does not hinge on a minimum principal amount of notes being tendered.
• - New Notes Condition: The consummation of the tender offer is subject to specific conditions, including the successful completion of a proposed offering of USD-denominated Senior Fixed Rate Notes.

Implications for Bondholders

For bondholders, this tender offer presents an opportunity to sell their notes prematurely at a set price without waiting for maturity. Those who decide to participate will be compensated with the Total Consideration, which includes both the offer price and any accrued interest up to the Settlement Date. This move may particularly appeal to investors looking to reallocate their portfolios or decrease their exposure to Haleon’s debt instruments.

Process of Participation

Bondholders interested in taking part in the tender offer must tender their notes before the expiration date. Once tendered, they may not withdraw participation unless under specific circumstances provided by law. It is recommended for holders to consult their financial intermediaries to understand submission requirements and timelines, as intermediaries may have their own deadlines prior to those set in Haleon’s announcement.

The Larger Picture: Haleon’s Financial Strategy

Haleon’s decision to initiate this tender offer aligns with its previously outlined capital allocation priorities, emphasizing proactive management of its financial commitments. The company has maintained a focus on sound fiscal practices to foster growth and innovation within its sprawling range of healthcare products. Brands under Haleon include well-known names such as Advil, Centrum, and Sensodyne, trusted by over a billion consumers globally.

By optimizing its debt with this tender offer, Haleon aims to fortify its balance sheet, enabling more flexibility and future investment in product development and market expansion. The forthcoming issuance of new bonds, concurrent with this offer, can provide further financial stability and enhance their cash flow management.

Conclusion

In conclusion, Haleon plc’s tender offer serves as a strategic maneuver to optimize its outstanding debt and aligns with the company’s commitment to maintaining robust financial practices. Stakeholders and bondholders are invited to consider this offer and make informed decisions ahead of the upcoming expiration date. For further details, they can consult the official documents available through Haleon's communication channels.